Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

10.19 -0.07 (-0.72%)
Streaming Delayed Price Updated: 9:52 AM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,985
Open 10.45
Bid (Size) 10.15 (200)
Ask (Size) 10.27 (700)
Prev. Close 10.26
Today's Range 10.19 - 10.45
52wk Range 10.07 - 10.32
Shares Outstanding 71,355,872
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share ↗
 
Via Benzinga
News headline image
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market ↗
Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years. 
Via Benzinga

Performance

YTD
-0.7%
-0.7%
1 Month
-0.7%
-0.7%
3 Month
-0.7%
-0.7%
6 Month
-0.7%
-0.7%
1 Year
-0.7%
-0.7%

More News

Read More
News headline image
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
From ChemoCentryx, Inc.
Via GlobeNewswire
News headline image
Biotech Stocks Well-Positioned For The Fourth Quarter ↗
Via Talk Markets
News headline image
ChemoCentryx: Q2 Earnings Insights ↗
Via Benzinga
News headline image
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From ChemoCentryx, Inc.
Via GlobeNewswire
News headline image
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗
Via Talk Markets
News headline image
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year ↗
Via Investor's Business Daily
News headline image
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗
Via Investor's Business Daily
News headline image
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
7 Dow Stocks With Superior Fundamentals ↗
Via InvestorPlace
News headline image
Healthcare Sector Still Looks Good But Lacks Momentum ↗
Via Talk Markets
News headline image
ChemoCentryx's Return On Capital Employed Insights ↗
Via Benzinga
News headline image
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗
Via Investor's Business Daily
News headline image
Whither Small Caps After Fed’s Tough Talk? ↗
Via Talk Markets
News headline image
Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million ↗
Via Investor's Business Daily
News headline image
Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation? ↗
Via Talk Markets
News headline image
Why Jim Cramer Says This Financial Stock Is 'Terrific' ↗
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022 ↗
Via Benzinga
News headline image
Earnings Preview: ChemoCentryx ↗
Via Benzinga
News headline image
Small Cap Biotechs Perk Up On Dealmaking ↗
Via Talk Markets
News headline image
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review ↗
Via Investor's Business Daily
News headline image
Where ChemoCentryx Stands With Analysts ↗
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022 ↗
Via Benzinga

Frequently Asked Questions

Is Churchill Capital Corp XI - Class A Ordinary Shares publicly traded?
Yes, Churchill Capital Corp XI - Class A Ordinary Shares is publicly traded.
What exchange does Churchill Capital Corp XI - Class A Ordinary Shares trade on?
Churchill Capital Corp XI - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Churchill Capital Corp XI - Class A Ordinary Shares?
The ticker symbol for Churchill Capital Corp XI - Class A Ordinary Shares is CCXI on the Nasdaq Stock Market
What is the current price of Churchill Capital Corp XI - Class A Ordinary Shares?
The current price of Churchill Capital Corp XI - Class A Ordinary Shares is 10.19
When was Churchill Capital Corp XI - Class A Ordinary Shares last traded?
The last trade of Churchill Capital Corp XI - Class A Ordinary Shares was at 02/10/26 09:52 AM ET
What is the market capitalization of Churchill Capital Corp XI - Class A Ordinary Shares?
The market capitalization of Churchill Capital Corp XI - Class A Ordinary Shares is 726.82M
How many shares of Churchill Capital Corp XI - Class A Ordinary Shares are outstanding?
Churchill Capital Corp XI - Class A Ordinary Shares has 727M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.